# Histogenics Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/histogenics

- Industry: Biotechnology
- Headquarters: Waltham, US
- Website: www.histogenics.com
- Total disclosed funding: $70M
- Latest round: Series A (Dec 18, 2013)
- Investors on record: 12

## About

Histogenics Corporation engages in the development and commercialization of regenerative medicine products, focusing on cartilage repair and tissue regeneration therapies for orthopedic applications.Histogenics Corporation was founded in 2000 and is headquartered in Waltham, US. The company specializes in regenerative medicine, particularly in cartilage repair and tissue regeneration. The most recent investment was a PIPE round in December 2014, raising USD 0.03 mn, which contributed to a total amount raised of USD 0.03 mn. The firm has executed 12 deals to date and has not undergone any notable changes in its business strategy or operations.Histogenics Corporation's primary offerings involve regenerative medicine products aimed at enhancing cartilage repair and regeneration in orthopedic applications. These products are designed to improve patient outcomes through innovative treatments that promote healing and recovery.In 2018, Histogenics Corporation reported a revenue of USD 0 mn and an EBITDA of USD -29,658,000.Histogenics Corporation plans to leverage its recent funding from the PIPE round in December 2014 to support the development and commercialization of new regenerative products. The company aims to expand its market presence in North America and Europe, with specific targets for new product launches in the next two years, enhancing its portfolio in cartilage repair therapies.

## Funding rounds

- Series A, Dec 18, 2013, $10M — Sofinnova Investments, Foundation Medical Partners, Split Rock Partners, FGI Capital Partners
- Series A, Jul 23, 2012, $37M — Boston Millennia Partners, Sofinnova Investments, Foundation Medical Partners, Gimv, BioMed Partners, Split Rock Partners, Altima Partners, Inflection Point Ventures, FGF Management, ProChon Holdings BV
- Series B, Sep 2, 2008, $9M — Boston Millennia Partners, Foundation Medical Partners, Altima Partners, Inflection Point Ventures, Stryker Corporation
- Series A, Aug 1, 2006, $13M — Boston Millennia Partners, Foundation Medical Partners, Stryker Corporation

## Investors

- Boston Millennia Partners (https://capitalatlas.ai/funds/boston-millennia-partners) — Series A, Series B
- Foundation Medical Partners (https://capitalatlas.ai/funds/foundation-medical-partners) — Series A, Series B
- Stryker Corporation — Series A, Series B
- Altima Partners (https://capitalatlas.ai/funds/altima-partners) — Series B, Series A
- Inflection Point Ventures (https://capitalatlas.ai/funds/inflection-point-ventures) — Series B, Series A
- Sofinnova Investments (https://capitalatlas.ai/funds/sofinnova-investments) — Series A
- Gimv (https://capitalatlas.ai/funds/gimv) — Series A
- BioMed Partners (https://capitalatlas.ai/funds/biomed-partners) — Series A
- Split Rock Partners (https://capitalatlas.ai/funds/split-rock-partners) — Series A
- FGF Management (https://capitalatlas.ai/funds/fgf-management) — Series A
- ProChon Holdings BV — Series A
- FGI Capital Partners (https://capitalatlas.ai/funds/fgi-capital-partners) — Series A